Landau R
Paul Baerwald School of Social Work and Social Welfare, The Hebrew University of Jerusalem, Mount Scopus, Jerusalem, Israel.
J Med Ethics. 2008 Sep;34(9):e10. doi: 10.1136/jme.2007.023226.
On 9 May 2005, the Israeli Ministry of Health issued guidelines spelling out the conditions under which sex selection by preimplantation genetic diagnosis (PGD) for social purposes is to be permitted in Israel. This article first reviews the available medical methods for sex selection, the preference for children of a specific gender in various societies and the ethical controversies surrounding PGD for medical and social purposes in different countries. It focuses then on the question of whether procreative liberty or parental responsibility should be the centre of attention in this context. Finally, the article critically examines the new Israeli guidelines and their implications for the women undergoing the necessary medical treatments, for the children born as a result, for other members of the family and for society in general.
2005年5月9日,以色列卫生部发布了指导方针,详细说明了在以色列允许出于社会目的通过植入前基因诊断(PGD)进行性别选择的条件。本文首先回顾了现有的性别选择医学方法、不同社会对特定性别的孩子的偏好以及不同国家围绕出于医学和社会目的的PGD的伦理争议。接着,它聚焦于在这种情况下生育自由或父母责任是否应成为关注核心的问题。最后,本文批判性地审视了以色列的新指导方针及其对接受必要医疗的女性、由此出生的孩子、家庭其他成员以及整个社会的影响。